Squarepoint’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.6K | Buy |
23,810
+6,454
| +37% | +$19.9K | ﹤0.01% | 2556 |
|
|
2025
Q1 | $60.6K | Sell |
17,356
-160,743
| -90% | -$561K | ﹤0.01% | 2595 |
|
|
2024
Q4 | $582K | Buy |
178,099
+113,291
| +175% | +$370K | ﹤0.01% | 1863 |
|
|
2024
Q3 | $250K | Buy |
+64,808
| New | +$250K | ﹤0.01% | 2086 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2440 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2387 |
|
|
2023
Q1 | – | Sell |
-13,650
| Closed | -$31.8K | – | 2216 |
|
|
2022
Q4 | $31.8K | Buy |
+13,650
| New | +$31.8K | ﹤0.01% | 2176 |
|
|
2022
Q1 | – | Sell |
-40,014
| Closed | -$156K | – | 2169 |
|
|
2021
Q4 | $156K | Buy |
+40,014
| New | +$156K | ﹤0.01% | 2189 |
|
|
2021
Q2 | – | Sell |
-29,880
| Closed | -$100K | – | 2559 |
|
|
2021
Q1 | $100K | Buy |
+29,880
| New | +$100K | ﹤0.01% | 2364 |
|
|
2020
Q3 | – | Sell |
-322,225
| Closed | -$586K | – | 2278 |
|
|
2020
Q2 | $586K | Buy |
322,225
+279,982
| +663% | +$509K | 0.01% | 1212 |
|
|
2020
Q1 | $43K | Buy |
+42,243
| New | +$43K | ﹤0.01% | 1722 |
|
|
2019
Q3 | – | Sell |
-65,848
| Closed | -$137K | – | 2193 |
|
|
2019
Q2 | $137K | Buy |
+65,848
| New | +$137K | ﹤0.01% | 2104 |
|
|
2018
Q2 | – | Sell |
-13,300
| Closed | -$67K | – | 1715 |
|
|
2018
Q1 | $67K | Sell |
13,300
-300
| -2% | -$1.51K | ﹤0.01% | 1596 |
|
|
2017
Q4 | $69K | Buy |
13,600
+3,300
| +32% | +$16.7K | ﹤0.01% | 1986 |
|
|
2017
Q3 | $64K | Buy |
+10,300
| New | +$64K | ﹤0.01% | 1533 |
|
|
2017
Q1 | – | Sell |
-13,400
| Closed | -$33K | – | 1473 |
|
|
2016
Q4 | $33K | Buy |
+13,400
| New | +$33K | ﹤0.01% | 1716 |
|